Imaging the master regulator of the antioxidant response in non-small cell lung cancer with positron emission tomography
H. E. Greenwood, R. S. Edwards, W. E. Tyrrell…·T. H. Witney
This study uses PET imaging to assess NRF2 activation in NSCLC, showing [18F]FSPG as a marker of therapeutic resistance and a potential target for treatment.